These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 31377652)

  • 1. Separation and characterization of unknown impurities in latamoxef sodium by LC-Q-TOF MS and a summary of their positive-ion fragmentation regularities.
    He L; Qian J; Zhu P; Yang W; She Y
    J Pharm Biomed Anal; 2019 Oct; 175():112793. PubMed ID: 31377652
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation and characterization of unknown impurities and isomers in flomoxef sodium by LC-IT-TOF MS and study of their negative-ion fragmentation regularities.
    Yu X; Wang F; Li J; Shan W; Zhu B; Wang J
    J Pharm Biomed Anal; 2017 Jun; 140():81-90. PubMed ID: 28343077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis of teicoplanin impurities by two-dimensional ultra performance liquid chromatography-quadrupole/time-of-flight mass spectrometry].
    Shao W; Chen Y; Yuan H; Jin M; Zhou X; Qin Y; Yang H; He Y
    Se Pu; 2023 Feb; 41(2):195-204. PubMed ID: 36725716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of impurities in sodium cromoglycate drug substance and eye drops using LC-ESI-ion trap MS and LC-ESI-QTOF MS.
    Zhu P; Lu J; Wang Z; Su W; Chen Y; Schepdael AV; Adams E
    J Pharm Biomed Anal; 2017 Oct; 145():537-548. PubMed ID: 28756173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separation and characterization of allergenic polymerized impurities from cephalosporin for injection by trap free two-dimensional high performance size exclusion chromatography × reversed phase liquid chromatography coupled with ion trap time-of-flight mass spectrometry.
    Xu Y; Wang D; Zhu B; Tang L; Wang J
    J Pharm Biomed Anal; 2018 May; 154():425-432. PubMed ID: 29579634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of four unknown impurities in azithromycin and erythromycin imino ether using two-dimensional liquid chromatography coupled to high-resolution quadrupole time-of-flight mass spectrometry and nuclear magnetic resonance.
    Jin Y; Xu Y; Zhou J; Zhou Z; Wang J
    Rapid Commun Mass Spectrom; 2020 Jun; 34(11):e8772. PubMed ID: 32112476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Separation and Characterization of Unknown Impurities and Isomers in Cefminox Sodium and Study of the Forming Mechanisms of Impurities by Liquid Chromatography Coupled with Ion Trap/Time-Of-Flight Mass Spectrometry.
    Xu Y; Wang D; Tang L; Wang J
    J Chromatogr Sci; 2019 Mar; 57(3):204-212. PubMed ID: 30395207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Forced degradation and impurity profiling: recent trends in analytical perspectives.
    Jain D; Basniwal PK
    J Pharm Biomed Anal; 2013 Dec; 86():11-35. PubMed ID: 23969330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of impurity carryover and impurity profile in Febuxostat drug substance by LC-MS/MS technique.
    Kadivar MH; Sinha PK; Kushwah D; Jana P; Sharma H; Bapodra A
    J Pharm Biomed Anal; 2011 Dec; 56(4):749-57. PubMed ID: 21840659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of a trap-free two-dimensional liquid chromatography combined with ion trap/time-of-flight mass spectrometry for separation and characterization of impurities and isomers in cefpiramide.
    Wang J; Xu Y; Wen C; Wang Z
    Anal Chim Acta; 2017 Nov; 992():42-54. PubMed ID: 29054149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The application of multiple analyte adduct formation in the LC-MS
    Dziadosz M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():159-161. PubMed ID: 27978470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Separation and characterization of allergic polymerized impurities in cephalosporins by 2D-HPSEC×LC-IT-TOF MS.
    Xu Y; Wang D; Tang L; Wang J
    J Pharm Biomed Anal; 2017 Oct; 145():742-750. PubMed ID: 28806571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Impurity profile study of cefalotin sodium by two-dimensional liquid chromatography-quadrupole time-of-flight mass spectrometry].
    Qiu Y; Qin F; Wen H; Zhao J; Liu H; Yang M
    Se Pu; 2015 Dec; 33(12):1314-9. PubMed ID: 27097466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of the structures of photodegradation impurities and pathways of photodegradation of cilnidipine by liquid chromatography/Q-Orbitrap mass spectrometry.
    Zeng H; Wang F; Zhu B; Zhong W; Shan W; Wang J
    Rapid Commun Mass Spectrom; 2016 Aug; 30(15):1771-8. PubMed ID: 27426453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Highly efficient, selective, sensitive and stability indicating RP-HPLC-UV method for the quantitative determination of potential impurities and characterization of four novel impurities in eslicarbazepine acetate active pharmaceutical ingredient by LC/ESI-IT/MS/MS.
    Thomas S; Bharti A; Maddhesia PK; Shandilya S; Agarwal A; Dharamvir ; Biswas S; Bhansal V; Gupta AK; Tewari PK; Mathela CS
    J Pharm Biomed Anal; 2012 Mar; 61():165-75. PubMed ID: 22178334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of eight unknown impurities and analysis of their source in xinfujunsu and injection by liquid chromatography coupled with ion trap/time-of-flight mass spectrometry.
    Wang J; Tang K; Zhu B; Zheng S; Zheng J; Hong L
    J Pharm Biomed Anal; 2021 Sep; 204():114279. PubMed ID: 34340019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical practical aspects in the application of liquid chromatography-mass spectrometric studies for the characterization of impurities and degradation products.
    Narayanam M; Handa T; Sharma P; Jhajra S; Muthe PK; Dappili PK; Shah RP; Singh S
    J Pharm Biomed Anal; 2014 Jan; 87():191-217. PubMed ID: 23706957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a novel process-related impurity in commercial bendazac lysine eye drops by LC-ESI-QTOF/MS/MS and NMR.
    Zhu P; Yang W; Hong L; Cheng Q; Luo L; He J; Chen J
    J Pharm Biomed Anal; 2015 Mar; 107():437-43. PubMed ID: 25666544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel HPLC method for the determination of the impurities in desonide cream and characterization of its impurities by 2D LC-IT-TOF MS.
    Wang J; Zheng S; Xu Y; Hu H; Shen M; Tang L
    J Pharm Biomed Anal; 2018 Nov; 161():399-406. PubMed ID: 30205304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of impurities in vertilmicin sulfate by liquid chromatography ion-trap mass spectrometry.
    Yuan YZ; Zhang M; Fan XL; Hu CQ; Jin SH; Van Schepdael A; Hoogmartens J; Adams E
    J Pharm Biomed Anal; 2013 Jun; 80():1-8. PubMed ID: 23518304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.